MMV's Market Share Analysis for November 2025

Working towards a malaria-free world.

Health > Health Conditions and Concerns

Domainmmv.org

Year Founded1999

Employees51 - 200

Annual Revenue$75M - $100M

MMV's

MMV's (including company regionals)

mmv.org

See more website traffic and engagement information

MMV's Revenue up to November 2025 is 75M - 100M

revenue generated by MMV's top domains

MMV's top domains revenue over 3 years

Revenue for MMV's top domains

mmv.org75M - 100M

See more with Sales Intelligence

Total visits to MMV's's top domains

Understand MMV's market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mmv.org82.6K

See more with Sales Intelligence

Avg. visit duration in MMV's's top domains

Analyze MMV's engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mmv.org00:00:24

See more with Sales Intelligence

Avg. pageviews on MMV's's top domains

See how MMV's keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mmv.org1.75

See more with Sales Intelligence

MMV's top competitors by domain

Top similar sites in November 2025, ranked by their affinity

malariavaccine.orgCompany NameMalaria Vaccine InitiativeEmployees51 - 200HQUnited States, District of Columbia, Washington, D.C.Annual revenue$15M - $25MTotal visits5.2KHealth > Health Conditions and Concerns

Top technologies used by MMV's

These are the website technologies, by industry, used by MMV's top domains

Payment & Currencies (24)

PayPal

Advertising (6)

Google Adsense

Widget (6)

reCAPTCHA

Social (4)

Facebook Social Plugins

More Technologies

10

See all

News & Signals from MMV's

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMedicines for Malaria Venture is developing 2.5 mg and 5 mg dispersible tablets tailored for paediatric use.Through the Partnership for Vivax Elimination (PAVE) and funded by Unitaid, MMV partnered with Fosun Pharma to develop 2.5 mg and 5 mg dispersible tablets tailored for paediatric use.

NewsMedicines for Malaria Venture recognized as Action for Women's Health awardee.MMV announced as an Action for Women's Health awardee.

NewsAstellas Pharma Inc partners with Medicines for Malaria Venture.Astellas entered into a screening collaboration agreement with Medicines for Malaria Venture to discover antimalarial drugs.